ON was the most represented first clinical event in our entire cohort (more often bilateral in anti-MOG than anti-AQP4 in larger cohorts than ours [12, 33]), followed by myelitis and the simultaneous attack of both regions. The gene discussed is AQP4; the disease is myelitis.